Longevity · Launchpad care path

Sermorelin — growth-hormone support on the partner care path.

Sermorelin (Serm) is on the partner Launchpad contract. It was formerly marketed as an FDA-approved drug and discontinued for commercial reasons, which is why compounding may still be lawful — a partner clinician and licensed pharmacy decide. Livozo does not prescribe. Care is not live until Launchpad is wired.

At a glance

What this page is built to clarify.

Listed Launchpad SKU

On the Launchpad contract

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo. This page does not start care.

Listed Launchpad SKU

Sleep and recovery focus

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo. This page does not start care.

Listed Launchpad SKU

Partner clinician decides

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo. This page does not start care.

Clinical context

How to read this page.

These pages describe possible pathways, not a promise that any medication will be prescribed, shipped this week, or available in any state today. Livozo does not employ the prescriber. After Launchpad go-live, the clinical target is 50-state coverage via licensed partner clinicians. Louisiana blocks shipping of compounded GLP-1s.

Compounded sermorelin is not FDA-approved. It is not appropriate for everyone. Livozo does not offer it for athletic or bodybuilding enhancement, and does not claim live prescribing today.
  • Poor sleep or recovery
  • Body-composition goals
  • Energy and healthy-aging interest
  • Interest in GH support without exogenous HGH

Partner model

What the partner path can include later.

When Launchpad is wired

  • Partner-hosted health and medication intake
  • Baseline labs when the partner clinician indicates
  • Clinician-directed dosing if prescribed
  • Follow-up through the partner portal

Potential options

  • Compounded sermorelin (subcutaneous) when prescribed
  • No research-grade or gray-market peptides

Exact medication, formulation, quantity, refill timing, and pharmacy routing depend on the clinical partner, applicable law, and clinical appropriateness. The partner's licensed 503A pharmacy network — not an exclusive Red Rock claim — fulfills partner prescriptions if written. None of that is live today.

Next step

Coming soon — not a live clinic, enrollment, or prescription.

This is a Launchpad catalog listing under a coming-soon posture, not live clinician care. When Launchpad is wired, a marketing CTA will hand off to partner intake. Until then there is no enrollment, start-visit, or checkout path. No prescription, charge, or shipment happens from this site.